de Gruil, N.; Böhringer, S.; de Groot, S.; Pijl, H.; Kroep, J.R.; Swen, J.J.
IGF1 and Insulin Receptor Single Nucleotide Variants Associated with Response in HER2-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without a Fasting Mimicking Diet (BOOG 2013-04 DIRECT Trial). Cancers 2023, 15, 5872.
https://doi.org/10.3390/cancers15245872
AMA Style
de Gruil N, Böhringer S, de Groot S, Pijl H, Kroep JR, Swen JJ.
IGF1 and Insulin Receptor Single Nucleotide Variants Associated with Response in HER2-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without a Fasting Mimicking Diet (BOOG 2013-04 DIRECT Trial). Cancers. 2023; 15(24):5872.
https://doi.org/10.3390/cancers15245872
Chicago/Turabian Style
de Gruil, Nadia, Stefan Böhringer, Stefanie de Groot, Hanno Pijl, Judith R. Kroep, and Jesse J. Swen.
2023. "IGF1 and Insulin Receptor Single Nucleotide Variants Associated with Response in HER2-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without a Fasting Mimicking Diet (BOOG 2013-04 DIRECT Trial)" Cancers 15, no. 24: 5872.
https://doi.org/10.3390/cancers15245872
APA Style
de Gruil, N., Böhringer, S., de Groot, S., Pijl, H., Kroep, J. R., & Swen, J. J.
(2023). IGF1 and Insulin Receptor Single Nucleotide Variants Associated with Response in HER2-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without a Fasting Mimicking Diet (BOOG 2013-04 DIRECT Trial). Cancers, 15(24), 5872.
https://doi.org/10.3390/cancers15245872
